Article
16 Sep 2025
From Foods To Pharmaceuticals, MAHA Strategy Offers Broad Menu Of FDA Actions
AUTHORS CONTENT
Article
10 Sep 2025
FDA Continues Focus On Rare Disease Drug Development, Announces Evidence Principles
Article
29 Aug 2025
Congress Joins FDA In Focusing On Food Dye Limitations
Article
28 Aug 2025
OMUFA Reauthorization On Deck As Congress Returns From Recess
Article
26 Aug 2025
Akin Intelligence - July 2025
Article
14 Aug 2025
Citizen Petition Calls On FDA To Rethink Refined Carbs
Article
11 Aug 2025
FDA Moves Forward On Fluoropolymers
Article
11 Aug 2025
FDA Leads The Way On Fluoropolymers
Article
30 Jul 2025
FDA, HHS And USDA Serve Up Ultra-Processed Food RFI
Article
22 Jul 2025
FDA Green Lights Another Natural Food Color
Article
22 Jul 2025
FDA Announces AI Councils Amid Calls For Greater Agency Transparency
Article
15 Jul 2025
FDA Opens The Vault On Decision Letters—Releases Wave Of Drug And Biologic CRLs
Article
01 Jul 2025
HHS To Launch Campaign Promoting Wearable Devices
Article
25 Jun 2025
FDA Announces Commissioner's National Priority Voucher Program To Accelerate Drug Application Review Process And Support National Priorities
Article
19 Jun 2025
FDA Adds A Dose Of Clarity To The NDIN Process
Article
09 Jun 2025
No Appeal Of LDT Decision Means Ball Is Back In FDA's Court For Policy Clarification
Article
04 Jun 2025
Akin Intelligence - April 2025
Article
27 May 2025
MAHA Commission Report On Children's Health Takes Aim At Ultra-Processed Foods And Medication Practices, Among Other Targets
Article
15 May 2025
FDA Grants Three Natural Food Additive Petitions
Article
09 May 2025
The Trump Administration Seeks To Spur Domestic Drug Manufacturing With Regulatory Relief EO